NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PulseCath B.V.

PulseCath B.V.

Private
ArnhemHealthcare & Life Scienceshttps://www.pulsecath.com/

Last Round

Grant

Jun 1, 2025

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PulseCath B.V. is a medical device company that develops, manufactures, and markets percutaneous mechanical circulatory support systems for cardiologists and cardiac surgeons.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mechanical circulatory supportMCSleft ventricular assist deviceLVADpercutaneous heart pumppulsatile flowhemodynamic supportinterventional cardiologycardiogenic shockpercutaneous coronary interventionPCIcardiac unloadingminimally invasive cardiologycatheter-based device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PulseCath B.V. Comparables

Compare PulseCath B.V. with similar companies based on industry and business-model similarity.

PulseCath B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Procyrion
88%
Johnson & Johnson
82%
Supira Medical
81%

PulseCath B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2025
StrategicSep 17, 2021

Key People

Founding team and executive leadership

Oren Malchin

Chief Executive Officer

Executive Team

yoram karmon

President & CEO

Executive Team

PulseCath B.V. Investors

Notable investors and investment history

PulseCath B.V. investors
InvestorRounds
Eurostars SME programmeGrant
MedSciences CapitalStrategic
East Netherlands Development Agency (Oost NL)Strategic
Health InnovationsStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 99% MoM, reaching 2K.

  • May 12, 2026

    Monthly visitors increased 116% MoM.

PulseCath B.V. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PulseCath B.V. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PulseCath B.V.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersArnhem
Employee Range13
Year Founded2007
Last FundingJun 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.